Cite
HARVARD Citation
Zezos, P. et al. (2020). Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness. Journal of the Canadian Association of Gastroenterology. 3 (2), pp. 74-82. [Online].